NCPA's qAM

qAM

96 percent of pharmacists agree ...

by NCPA | Jan 04, 2019

...that eliminating retroactive pharmacy DIR fees is their top priority. We bet you're one of them. Good news: A new drug pricing proposed rule from CMS, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, eliminates retroactive DIR as we know it today. Please let CMS know that you support the proposed DIR provisions. We've made that quick and easy for you to do. Just submit sample comments on retroactive DIR through our grassroots portal. Don't wait until the last minute – submit your comment today! You'll find more info on our resources webpage, including a bag stuffer you can use to educate your patients on their potential out-of-pocket cost savings they'll realize under the proposal and background information for engaging your patients on this issue.